文献詳細
今月の臨床 性ホルモン製剤を使いこなす
エストロゲン製剤
文献概要
●エストロゲン製剤投与には注射・内服・経皮・経腟の4経路がある.
●エストロゲン製剤の投与経路により生体反応が変化する.
●個々の製剤の特徴と効果を踏まえたエストロゲン補充が望ましい.
●エストロゲン製剤の投与経路により生体反応が変化する.
●個々の製剤の特徴と効果を踏まえたエストロゲン補充が望ましい.
参考文献
1) 日本女性医学学会 : ホルモン補充療法ガイドライン2012年度版,2012
2) 玉舎輝彦(編) : 産婦人科薬物療法.新女性医学大系7(武谷雄二総編集).中山書店,2000
3) Barbieri RL : Hormone treatment of endometriosis : the estrogen threshold hypothesis. Am J Obstet Gynecol 166 : 740─745, 1992
4) Grady D, Rubin SM, Petitti DB, et al : Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117 : 1016─1037, 1992
5) Ettinger B, Ensrud KE, Wallace R, et al : Effects of ultralow-dose transdermal estradiol on bone mineral density : a randomized clinical trial. Obstet Gynecol 104 : 443─451, 2004
6) Prestwood KM, Kenny AM, Kleppinger A, et al : Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women : a randomized controlled trial. JAMA 290 : 1042─1048, 2003
7) Lobo RA, Pinkerton JV, Gass ML, et al : Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile. Fertil Steril 92 : 1025─1038, 2009
8) 日本生殖医学会ホームページより.http://plaza.umin.ac.jp/~jsog-art/data.htm
9) Devroey P, Pados G : Preparation of endometrium for egg donation. Hum Reprod Update 4 : 856─861, 1998
10) Groenewoud, ER, Cantineau, AE, Kollen BJ, et al : What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update 19 : 458─470, 2013
11) Glujovsky D, Pesce R, Fiszbajn G, et al : Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev CD006359, 2010
12) Cardozo L, Bachmann G, McClish D, et al : Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women : second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 92 : 722─727, 1998
13) Palacios S, Castelo-Branco C, Cancelo MJ, et al : Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas 50 : 98─104, 2005
14) Fantl JA, Cardozo L, McClish DK : Estrogen therapy in the management of urinary incontinence in postmenopausal women : a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 83 : 12─18, 1994
15) Hendrix SL, Cochrane BB, Nygaard IE, et al : Effects of estrogen with and without progestin on urinary incontinence. JAMA 293 : 935─948, 2005
16) Cody JD, Richardson K, Moehrer B, et al : Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev, CD001405, 2009
17) Cardozo L, Lose G, McClish D, et al : A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 83 : 892─897, 2004
18) Weiderpass E, Baron JA, Adami HO, et al : Low-potency oestrogen and risk of endometrial cancer : a case-control study. Lancet 353 : 1824─1828, 1999
掲載誌情報